All Kits & Reagents
All Selection & Planning Tools
All Software & Informatics Products
All Popular Products
All Informatics Education
More About Us
More Career Info
All Investor Information
More Business Solutions
All Legal Information
All Support Tools
All Product Support Services
Enable comprehensive genomic profiling with accurate and comprehensive homologous recombination deficiency assessment
All Cancer Research Products
All Microbial Genomics Research
Metagenomic and metatranscriptomic results from research on the microbiomes of an isolated tribe living deep in the Amazon
All Microbial Genomics Products
All Informatics Products
Learn about eDNA through sequencing the seas
All Agrigenomics Products
Improving our understanding of biological systems in health and disease
All Complex Disease Research Products
The NovaSeq 6000Dx is our first IVD-compliant high-throughput sequencing instrument for the clinical lab
All Reproductive Health
All Reproductive Health Products
All Genetic Health Products
Using a single test assessing hundreds of current and
emerging cancer biomarkers, you can now access a
clinically relevant report with actionable answers.
The MiSeqDx instrument is the first FDA-cleared <i>in vitro</i> diagnostic (IVD) next-generation sequencing (NGS) system.
MiSeqDx applications include FDA-cleared and FDA-approved assays for cystic fibrosis testing, colorectal cancer evaluation, and NGS-based assay development.
FDA-cleared next-generation sequencing panels for detection of causative and clinically relevant variants for cystic fibrosis.